# Pramlintide plus insulin (ADO09) in type 1 diabetes

Source: https://pepvault.app/research/pramlintide-andersen-2023

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Pramlintide](https://pepvault.app/research#pramlintide)

Randomized trial · people

# Pramlintide/insulin ADO09 cut meal glucose rise 69% in high-dose group

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

Putting pramlintide and insulin in one mealtime shot improved short-term glucose control and weight compared with aspart, with slightly more low blood sugar events and gut side effects.

- **Kind:** Randomized trial
- **Studied in:** People
- **Published:** 2023
- **Journal:** Diabetes Obes Metab

## What they tested

The team tested whether ADO09, a single shot that combines pramlintide with insulin A21G, controls blood sugar better than insulin aspart in adults with type 1 diabetes.

## How the study was done

A double-blind, randomized crossover trial: each adult with type 1 diabetes used ADO09 and insulin aspart at mealtimes, for 24 days each. People were split by their daily mealtime insulin needs into a low-dose group of 28 (40 U or less) and a high-dose group of 16 (40 to 75 U).

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking pramlintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

The main measure was the rise in blood sugar over the 4 hours after a test meal. With ADO09 that rise was 69% lower in the high-dose group, and 39% lower in the low-dose group, though the low-dose result was not statistically significant. On continuous glucose monitors in daily life, average glucose was lower with ADO09 in both groups (by 8.2 ± 7.9 mg/dl in the low-dose group), and time in range (70-180 mg/dl) rose by 4% in each group. Body weight fell by 0.8 kg in the low-dose group and 1.6 kg in the high-dose group, while low blood sugar events were a little more common with ADO09 (142 vs. 115 and 96 vs. 79), and gut side effects were more frequent but mostly passed.

## What it doesn’t show

Each treatment period lasted only 24 days and the groups were small, so this does not show long-term effects. It tested pramlintide combined with insulin A21G in one shot, not pramlintide on its own.

## The paper

Andersen et al. A co-formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short-term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes. Diabetes Obes Metab. 2023.

- [PubMed (PMID 36633505)](https://pubmed.ncbi.nlm.nih.gov/36633505/)
- [The paper (DOI 10.1111/dom.14972)](https://doi.org/10.1111/dom.14972)
- [ClinicalTrials.gov (NCT03981627)](https://clinicaltrials.gov/study/NCT03981627)

## The compound

- [Pramlintide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/pramlintide)
- [Pramlintide dose guide](https://pepvault.app/lab/dosage/pramlintide)

## With this study

### Pramlintide

- [Pramlintide: the full reference](https://pepvault.app/peptides/pramlintide)
- [Pramlintide dose guide](https://pepvault.app/lab/dosage/pramlintide)

### Studies

- [Pramlintide: HbA1c down 0.43% vs placebo at 26 weeks with insulin](https://pepvault.app/research/pramlintide-hollander-2003)
- [Pramlintide-insulin loop: time in range held without carb counting](https://pepvault.app/research/pramlintide-odabassian-2025)
- [Pramlintide-insulin mix: 2.1 kg more weight loss than lispro](https://pepvault.app/research/pramlintide-andersen-2024)
- [All 8 studies](https://pepvault.app/research#pramlintide)

### Compared with

- [Cagrilintide vs Pramlintide](https://pepvault.app/peptides/compare/cagrilintide-vs-pramlintide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)
- [Crossover trial](https://pepvault.app/glossary/crossover-trial)

## More studies on Pramlintide

- [Pramlintide: HbA1c down 0.43% vs placebo at 26 weeks with insulin](https://pepvault.app/research/pramlintide-hollander-2003) Meta-analysis · people · 2003
- [Pramlintide-insulin loop: time in range held without carb counting](https://pepvault.app/research/pramlintide-odabassian-2025) Randomized trial · people · 2025
- [Pramlintide-insulin mix: 2.1 kg more weight loss than lispro](https://pepvault.app/research/pramlintide-andersen-2024) Randomized trial · people · 2024
- [Pramlintide: weight loss maintained over 12 months in obesity](https://pepvault.app/research/pramlintide-smith-2008) Randomized trial · people · 2008
- [Pramlintide: 3.7% placebo-corrected weight loss at 16 weeks](https://pepvault.app/research/pramlintide-aronne-2007) Randomized trial · people · 2007
- [Pramlintide lowered post-meal glucagon and glucose in type 2 diabetes](https://pepvault.app/research/pramlintide-fineman-2002) Randomized trial · people · 2002
- [Every study on Pramlintide](https://pepvault.app/research#pramlintide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking pramlintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking pramlintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Pramlintide

- [Pramlintide: the full reference](https://pepvault.app/peptides/pramlintide)
- [Pramlintide dose guide](https://pepvault.app/lab/dosage/pramlintide)

### Studies

- [Pramlintide: HbA1c down 0.43% vs placebo at 26 weeks with insulin](https://pepvault.app/research/pramlintide-hollander-2003)
- [Pramlintide-insulin loop: time in range held without carb counting](https://pepvault.app/research/pramlintide-odabassian-2025)
- [Pramlintide-insulin mix: 2.1 kg more weight loss than lispro](https://pepvault.app/research/pramlintide-andersen-2024)
- [All 8 studies](https://pepvault.app/research#pramlintide)

### Compared with

- [Cagrilintide vs Pramlintide](https://pepvault.app/peptides/compare/cagrilintide-vs-pramlintide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)
- [Crossover trial](https://pepvault.app/glossary/crossover-trial)

<!--promo-->

PepVault for iPhone

## Taking pramlintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Pramlintide](https://pepvault.app/research#pramlintide)

## The library

- [Pramlintide](https://pepvault.app/peptides/pramlintide)
- [Pramlintide dose guide](https://pepvault.app/lab/dosage/pramlintide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
